HIV/AIDS Topics AIDS 2016: New HIV Vaccine Efficacy Trial Set to Start this Year
- Details
- Category: HIV Vaccines
- Published on Friday, 22 July 2016 00:00
- Written by Gus Cairns
A new efficacy trial for an HIV vaccine -- only the seventh ever conducted in the history of the epidemic -- will start this November, delegates heard at the 21st International AIDS Conference (AIDS 2016) taking place this week in Durban. The HVTN 702 study will enroll 5400 men and women in southern Africa, and is planned to last for 4 years. In May it was announced that a pilot study, HVTN 100, had met the criteria for the vaccine being taken forward into the larger study. But this week was the first time researchers revealed how well it had met those criteria.
AIDS 2016: SEARCH Study Exceeds 90-90-90 Targets After 2 Years of HIV Test-and-Treat
- Details
- Category: Treatment as Prevention
- Published on Friday, 22 July 2016 00:00
- Written by Keith Alcorn
A large study that embeds "'test-and-treat" for HIV within a larger multi-disease prevention campaign in rural Kenya and Uganda has achieved 82% viral suppression after 2 years, and has already exceeded UNAIDS targets for viral suppression after 1 year of activity, investigators from the SEARCH study reported at the 21st International AIDS Conference (AIDS 2016) this week in Durban.
AIDS 2016: Young Gay Men Can Do Well on PrEP, But May Need More Support
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 20 July 2016 00:00
- Written by Liz Highleyman
Young gay and bisexual men had good adherence to Truvada for pre-exposure prophylaxis (PrEP) during the first few months of a demonstration project with close monitoring, but adherence slipped once follow-up switched from monthly to quarterly, suggesting that young people using PrEP may require more on-going support, according to a presentation at the 21st International AIDS Conference (AIDS 2016) this week in Durban.
AIDS 2016: Australia Adopts Ambitious Plan to Use PrEP to "Virtually Eliminate" HIV
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 22 July 2016 00:00
- Written by Gus Cairns
Australia plans an ambitious program of pre-exposure prophylaxis (PrEP) provision for gay men at high risk of HIV, with the aim of "virtually eliminating" HIV in the gay community by 2020, Iryna Zablotska from the University of New South Wales told delegates at the 21st International AIDS Conference (AIDS 2016) this week in Durban. PrEP roll-out is also underway in some countries in Kenya and South Africa.
AIDS 2016: PrEP Can Further Reduce HIV Risk After Partner Starts Antiretroviral Treatment
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Wednesday, 20 July 2016 00:00
- Written by Liz Highleyman
Offering Truvada pre-exposure prophylaxis (PrEP) to the HIV-negative partner in a serodiscordant couple during the first 6 months after the HIV-positive partner starts antiretroviral therapy (ART) can serve as a "bridge" to further reduce the likelihood of HIV infection, researchers reported at the 21st International AIDS Conference (AIDS 2016) taking place this week in Durban, South Africa.
Web Design and Development by